Clinical Trials Logo

Clinical Trial Summary

Demonstrate the effectiveness of Belotero Balance with lidocaine (Test group) for the reduction of injection-related pain in comparison to Belotero Balance without lidocaine (Control group) for the correction of NLFs.

Identify and describe adverse events (AEs) and serious adverse events (SAEs) during the course of the study. Additionally, common treatment site responses (CTRs) will be assessed.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Correction of Moderate to Severe Nasolabial Folds

NCT number NCT03319719
Study type Interventional
Source Merz North America, Inc.
Contact
Status Completed
Phase N/A
Start date September 18, 2017
Completion date December 6, 2017